Skip to content
Biodatica
Start free

Investigator

Charles Gellman

HIDO TECHNOLOGIES, INC. · funded by NIA

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$3.7M

Summed across those awards.

First award
Aug 15, 2022

Latest Sep 20, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place

    $1.2M

    Sep 20, 2025NIAHIDO TECHNOLOGIES, INC.NIH RePORTER · 11254881 (opens the source filing in a new tab)

  2. R44

    Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place

    $1.2M

    Sep 20, 2025NIAHIDO TECHNOLOGIES, INC.NIH RePORTER · 11418517 (opens the source filing in a new tab)

  3. R44

    Preventing Medication Mismanagement in People Living with Dementia through Automated Medication Dispensing with Facial Recognition and Video Observation

    $1.2M

    Aug 15, 2022NIAHIDO TECHNOLOGIES, INC.NIH RePORTER · 11196749 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources